Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 7, 2009, Pages 3151-3158

  Hayashi, Takahiko ^a   Yamagami, Satoru ^b,c   Tanaka, Kazumi ^a   Yokoo, Seiichi ^d   Usui, Tomohiko ^d   Amano, Shiro ^d   Mizuki, Nobuhisa ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIAL CELL TRANSPLANTATION; CORNEA TRANSPLANTATION; CULTURE TECHNIQUE; DELAYED HYPERSENSITIVITY; GRAFT REJECTION; GRAFT SURVIVAL; KERATOPATHY; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RETRANSPLANTATION; SPLEEN CELL; SURVIVAL RATE; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CORNEA; CORNEA DISEASE; CORNEA ENDOTHELIUM; CYTOLOGY; FLUORESCENCE MICROSCOPY; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE; PASSIVE IMMUNIZATION; PHYSIOLOGY; REOPERATION; SPLEEN; TRANSPLANTATION;

ALLOANTIGEN;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; ENDOTHELIUM, CORNEAL; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; IMMUNIZATION, PASSIVE; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; REOPERATION; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 67649983289     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2530     Document Type: Article

References (59)

1. Maumenee AE. The influence of donor-recipient sensitization on corneal grafts. Am J Ophthalmol. 1951;34:142-152.
2. The Collaborative Corneal Transplantation Studies Research Group. The Collaborative Corneal Transplantation Studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol. 1992;110:1392-1403.
3. Borboli S, Colby K. Mechanisms of disease: Fuch's endothelial dystrophy. Ophthalmol Clin North Am. 2002;15:17-25.
4. Stechschulte SU, Azar DT. Complications after penetrating keratoplasty. Int Ophthalmol Clin. 2000;40:27-43.
5. Melles GR, Eggink FA, Lander F, et al. A surgical technique for posterior lamellar keratoplasty. Cornea. 1998;17:618-626.
6. Terry MA, Ousley PJ. Replacing the endothelium without corneal surface incisions or sutures: the first United States clinical series using the deep lamellar endothelial keratoplasty procedure. Ophthalmology. 2003;110:755-764.
7. Terry MA, Ousley PJ. In pursuit of emmetropia: spherical equivalent refraction results with deep lamellar endothelial keratoplasty (DLEK). Cornea. 2003;22:619-626.
8. Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea. 2006;25:886-889.
9. Mimura T, Shimomura N, Usui T, et al. Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet's membrane. Exp Eye Res. 2003;76:745-751.
10. Mimura T, Yamagami S, Usui T, et al. Long-term outcome of iron-endocytosing cultured corneal endothelial cell transplantation with magnetic attraction. Exp Eye Res. 2005;80:149-157.
11. Mimura T, Yamagami S, Yokoo S, et al. Sphere therapy for corneal endothelium deficiency in a rabbit model. Invest Ophthalmol Vis Sci. 2005;46:3128-3135.
12. Mimura T, Yokoo S, Araie M, et al. Treatment of rabbit bullous keratopathy with precursors derived from cultured human corneal endothelium. Invest Ophthalmol Vis Sci. 2005;46:3637-3644.
13. Mimura T, Yamagami S, Yokoo S, et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci. 2004;45:2992-2997.
14. Hsiue GH, Lai JY, Chen KH, Hsu WM. A novel strategy for corneal endothelial reconstruction with a bioengineered cell sheet. Transplantation. 2006;81:473-476.
15. Niederkorn JY. The immune privilege of corneal allografts. Transplantation. 1999; 967:1503-1508.
16. Qian Y, Dana MR. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med. 2001;3:1-21.
17. Hori J, Streilein JW. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001;42:720-726.
18. Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among different layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:3032-3042.
19. Ohguro N, Matsuda M, Shimomura Y, Inoue Y, Tano Y. Effects of penetrating keratoplasty rejection on the endothelium of the donor cornea and the recipient peripheral cornea. Am J Ophthalmol. 2000;129:468-471.
20. Claerhout I, Beele H, De Bacquer D, Kestelyn P. Factors influencing the decline in endothelial cell density after corneal allograft rejection. Invest Ophthalmol Vis Sci. 2003;44:4747-4752.
21. Barcia RN, Dana MR, Kazlauskas A. Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with bcl-xL. Am J Transplant. 2007;7:2082-2089.
22. Plskova J, Kuffova L, Filipec M, Holan V, Forrester JV. Quantitative evaluation of the corneal endothelium in the mouse after grafting. Br J Ophthalmol. 2004;88:1209-1216.
23. Hayashi T, Yamagami S, Tanaka K, et al. A mouse model of allogeneic corneal endothelial cell transplantation. Cornea. 2008; 27:699-705.
24. Yue BYJT, Sugar J, Gilboy JE, Elvart JL. Growth of human corneal endothelial cells in culture. Invest Ophthalmol Vis Sci. 1989;30: 248-253.
25. Joo CK, Pepose JS, Fleming TP. In vitro propagation of primary and extended life span murine corneal endothelial cells. Invest Ophthalmol Vis Sci. 1994;35:3952-3957.
26. Joo CK, Green WR, Pepose JS, Fleming TP. Repopulation of denuded murine Descemet's membrane with life-extended murine corneal endothelial cells as a model for corneal cell transplantation. Graefes Arch Clin Exp Ophthalmol. 2000;238:174-180.
27. Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci. 1996;37:2700-2707.
28. Yang HJ, Sato T, Matsubara M, Tanishima T. Endothelial woundhealing in penetrating corneal graft for experimental bullous keratopathy in rabbit. Jpn J Ophthalmol. 1985;29:378-393.
29. Yamada J, Hamuro J, Sano Y, Maruyama K, Kinoshita S. Allogeneic corneal tolerance in rodents with long-term graft survival. Transplantation. 2005;79:1362-1369.
30. Cetkovic-Cvrlje M, Roers BA, Waurzyniak B, Liu XP, Uckun FM. Targeting Janus kinase 3 to attenuate the severity of acute graftversus-host disease across the major histocompatibility barrier in mice. Blood. 2001;98:1607-1613.
31. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol. 1993; 150:1727-1734.
32. Plskova J, Holan V, Filipec M, Forrester JV. Lymph node removal enhances corneal graft survival in mice at high risk of rejection. BMC Ophthalmol. 2004;4:3.
33. Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol. 2002;168:2028-2034.
34. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci. 2001;42:1293-1298.
35. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666-2673.
36. Musch DC, Schwartz AE, Fitzgerald-Shelton K, Sugar A, Meyer RF. The effect of allograft rejection after penetrating keratoplasty on central endothelial cell density. Am J Ophthalmol. 1991;111:739-742.
37. Bourne WM. Biology of the corneal endothelium in health and disease. Eye. 2003;17:912-918.
38. Hori J, Streilein JW. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001;42:1820-1828.
39. + T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci. 1999;40:2614-2621.
40. + T cells in allorecognition: lessons from corneal transplantation. J Immunol. 2001;67:1891-1899.
41. Sano Y, Streilein JW, Ksander BR. Detection of minor alloantigenspecific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway." Transplantation. 1999;68: 963-970.
42. Yamada J, Ksander BR, Streilein JW. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001;42:386-392.
43. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol. 2007;179:3672-3679.
44. Beauregard C, Stevens C, Mayhew E, Niederkorn JY. Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol. 2005;174:6577-6581.
45. Hargrave SL, Hay C, Mellon J, Mayhew E, Niederkorn JY. Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci. 2004;45:1188-1193.
46. + regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant. 2007;7:1457-1463.
47. Tao R, Hancock WW. Regulating regulatory T cells to achieve transplant tolerance. Hepatobiliary Pancreat Dis Int. 2007;6:348-357.
48. + regulatory T cells are new therapeutic targets. Front Biosci. 2008;13:1472-1499.
49. Akl A, Luo S, Wood KJ. Induction of transplantation tolerance-the potential of regulatory T cells. Transpl Immunol. 2005;14:225-230.
50. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation. 1997;64:1107-1111.
51. Hori J, Wang M, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006;177:5928-5935.
52. + T helper 1 cells by a contact-dependent mechanism. Invest Ophthalmol Vis Sci. 2009;50:263-272.
53. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449.
54. Stuart PM, Griffith TS, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
55. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005;23:515-548.
56. Ryu YH, Kim JC. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor. Invest Ophthalmol Vis Sci. 2007;48:4148-4152.
57. Beutelspacher SC, Pillai R, Watson MP, et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol. 2006;36: 690-700.
58. Chen X, Liu L, Yang P, et al. Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation. Immunol Lett. 2006;107:140-147.
59. Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol. 2009;182:148-153.